Blokes, presented on the Joi + Blokes website, advertises a testosterone program starting at $99 per month. Its detailed pricing makes an important distinction: that rate is attached to a full-year commitment and a larger upfront payment. The shortest listed plan also involves several months.

This review uses the provider’s public TRT page and relevant primary sources checked September 26, 2026. It covers the financial commitment, proposed medicine, ongoing care, and a separate FDA warning-letter record. We have not enrolled, assessed treatment results, or tested customer support.

KEEP IN MIND

The useful bits.

  • The $99 rate is attached to $1,188 upfront for a year.
  • Confirm state restrictions and the actual dispensed preparation.
  • The June 2026 FDA letter concerns GLP-1 promotion; its later resolution was not established.

Compare the amount due today

The published Flex plan is $149 monthly equivalent for three months, with $447 upfront. The six-month plan lists $129 monthly equivalent and $774 upfront. The $99 rate requires a 12-month commitment with $1,188 paid upfront. These are different commitments, not three month-to-month prices.

Ask for the terms that apply if the clinician changes or stops treatment, if you move to an unsupported state, or if you want to leave before the paid period ends. A statement about easy cancellation does not by itself establish a prorated refund. Keep the full quote and terms with the receipt so the financial decision is based on the actual agreement.

Sources: Joi + Blokes: TRT plan commitments, products, labs, and state restrictions

Identify the prescription behind the package

The service page names testosterone cypionate and describes delivery of medicine and supplies. It also states that products may be compounded. That disclosure does not identify which specific preparation or pharmacy a particular patient will receive. Request those details before treating the package as equivalent to a named FDA-approved product.

Compounded drugs do not have FDA approval. The compounded and approved testosterone guide explains the distinction. Ask why the proposed preparation is suitable and how you receive training, storage guidance, and answers about the label. We do not infer a universal concentration, injection schedule, or pharmacy from the provider’s general offer.

Sources: Joi + Blokes: TRT plan commitments, products, labs, and state restrictions · FDA: understanding the risks of compounded drugs

Confirm access before ordering an assessment

Blokes publishes a substantial list of states where it says it cannot prescribe or ship TRT. Confirm current access for your address directly against the provider’s list and during intake. The ability to browse a store or pay for laboratory work is not proof that testosterone treatment can be provided where you live.

Medical eligibility is a separate issue. A clinician should consider symptoms, appropriately confirmed laboratory findings, and the cause of low testosterone. Bring prior results and medication information. Ask what you would owe if the assessment does not support treatment, and whether any initial testing expense is separate from the advertised subscription.

Sources: Joi + Blokes: TRT plan commitments, products, labs, and state restrictions · Endocrine Society: testosterone therapy clinical guidance

Quarterly labs should lead to a clear review process

The program advertises quarterly hormone labs, clinician visits, and messaging. Ask which tests are included and what happens if additional testing is needed earlier. A scheduled panel is only part of continuing care; you also need to know who interprets it and how the result changes the plan.

Discuss blood pressure, blood counts, symptoms, and fertility goals with the prescriber as appropriate. Our blood-pressure monitoring article can help prepare questions. We have not measured the speed or quality of Blokes’ clinical responses. Access claims should remain distinguishable from demonstrated patient experience or a guarantee that a particular outcome will occur.

Sources: Joi + Blokes: TRT plan commitments, products, labs, and state restrictions · Endocrine Society: testosterone therapy clinical guidance · FDA: 2025 testosterone labeling and blood pressure changes

Read the FDA record in its actual scope

FDA issued a warning letter to Joi and Blokes on June 8, 2026 concerning misleading promotion of compounded semaglutide and tirzepatide, including how the compounder was represented. Those are GLP-1-related products, and the letter should not be described as a finding about a specific TRT prescription.

We have not established the subsequent resolution of that letter. It is relevant background when assessing provider claims, not a basis for inventing a testosterone safety result or a current enforcement status. Read the linked primary document and ask the company about corrective actions if this affects your decision. Separate the products and claims discussed from unrelated treatment assumptions.

Sources: FDA: June 8, 2026 warning letter concerning Joi + Blokes compounded GLP-1 promotion

Decide with both the care plan and exit terms

A prepaid package may suit someone who understands the commitment and has confirmed appropriate care and state access. It may be less convenient when the treatment plan or location could change. The lowest monthly equivalent does not establish the smallest risk of unused prepaid services or the best clinical fit.

Our Blokes versus TRT Nation comparison puts the different purchase terms side by side. The upfront-payment shortlist offers a wider set of questions. Before choosing, request the medicine, pharmacy, testing scope, first payment, renewal process, and written handling of a medically necessary change. A clear answer is more useful than a headline saving.

Sources: Joi + Blokes: TRT plan commitments, products, labs, and state restrictions · TRT Nation: current testosterone treatment prices and minimum purchase

Sources you can check

Provider pages describe commercial offers. Medical references provide context. Checked September 26, 2026; prices and availability can change.

  1. Joi + Blokes: TRT plan commitments, products, labs, and state restrictions
  2. FDA: understanding the risks of compounded drugs
  3. Endocrine Society: testosterone therapy clinical guidance
  4. FDA: 2025 testosterone labeling and blood pressure changes
  5. FDA: June 8, 2026 warning letter concerning Joi + Blokes compounded GLP-1 promotion
  6. TRT Nation: current testosterone treatment prices and minimum purchase

Educational information for adults, not a diagnosis or treatment plan. Discuss symptoms and treatment decisions with a licensed clinician. Do not change a prescription based on this article.